UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
+$21.9B |
| 2 |
Amazon
AMZN
|
+$15.2B |
| 3 |
NVIDIA
NVDA
|
+$4.85B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.03B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.67B |
Top Sells
| 1 |
Microsoft
MSFT
|
+$26B |
| 2 |
Equinix
EQIX
|
+$803M |
| 3 |
NetEase
NTES
|
+$723M |
| 4 |
Digital Realty Trust
DLR
|
+$699M |
| 5 |
Bank of New York Mellon
BK
|
+$653M |
Sector Composition
| 1 | Technology | 31.92% |
| 2 | Financials | 13.89% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.69% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Madison Square Garden
MSGE
$2.1B
| $4.1M | ﹤0.01% |
102,683
+70,337
| +217% | +$2.81M |
|
1802
Universal Corp
UVV
$1.38B
| $4.1M | ﹤0.01% |
70,381
+33,423
| +90% | +$1.95M |
|
1803
Aurora
AUR
$10.5B
| $4.09M | ﹤0.01% |
781,253
-1,265,507
| -62% | -$6.63M |
|
1804
Equinox Gold
EQX
$8.29B
| $4.08M | ﹤0.01% |
709,692
-70,449
| -9% | -$405K |
|
1805
Icon
ICLR
$13.6B
| $4.08M | ﹤0.01% |
28,054
+3,347
| +14% | +$487K |
|
1806
Praxis Precision Medicines
PRAX
$794M
| $4.08M | ﹤0.01% |
96,945
+9,864
| +11% | +$415K |
|
1807
German American Bancorp
GABC
$1.53B
| $4.06M | ﹤0.01% |
105,503
+50,133
| +91% | +$1.93M |
|
1808
Protolabs
PRLB
$1.18B
| $4.06M | ﹤0.01% |
101,431
+22,240
| +28% | +$890K |
|
1809
Middlesex Water
MSEX
$971M
| $4.05M | ﹤0.01% |
74,779
+15,557
| +26% | +$843K |
|
1810
Bio-Rad Laboratories Class A
BIO
$7.59B
| $4.04M | ﹤0.01% |
16,749
-366,058
| -96% | -$88.3M |
|
1811
Westamerica Bancorp
WABC
$1.24B
| $4.04M | ﹤0.01% |
83,365
+19,314
| +30% | +$936K |
|
|
BOW
1812
Bowhead Specialty Holdings
BOW
$979M
| $4.03M | ﹤0.01% |
107,285
-10,082
| -9% | -$378K |
|
1813
REX American Resources
REX
$1.01B
| $4.02M | ﹤0.01% |
82,462
+218
| +0.3% | +$10.6K |
|
1814
Cannae Holdings
CNNE
$1.11B
| $4.01M | ﹤0.01% |
192,539
+20,472
| +12% | +$427K |
|
1815
Tenaris
TS
$18.7B
| $3.98M | ﹤0.01% |
106,460
-33,094
| -24% | -$1.24M |
|
1816
Sally Beauty Holdings
SBH
$1.48B
| $3.97M | ﹤0.01% |
428,658
+103,752
| +32% | +$961K |
|
1817
Xometry
XMTR
$2.59B
| $3.97M | ﹤0.01% |
117,378
+51,029
| +77% | +$1.72M |
|
1818
Crescent Energy
CRGY
$2.21B
| $3.97M | ﹤0.01% |
461,075
+216,619
| +89% | +$1.86M |
|
1819
NextNav
NN
$2.3B
| $3.96M | ﹤0.01% |
260,696
+125,818
| +93% | +$1.91M |
|
1820
Astrana Health
ASTH
$1.38B
| $3.94M | ﹤0.01% |
158,439
+54,333
| +52% | +$1.35M |
|
1821
Encore Capital Group
ECPG
$1.02B
| $3.93M | ﹤0.01% |
101,605
+23,140
| +29% | +$896K |
|
1822
BrightView Holdings
BV
$1.32B
| $3.93M | ﹤0.01% |
235,784
+64,710
| +38% | +$1.08M |
|
1823
Array Technologies
ARRY
$1.17B
| $3.92M | ﹤0.01% |
663,690
+111,715
| +20% | +$659K |
|
1824
Astec Industries
ASTE
$1.06B
| $3.9M | ﹤0.01% |
93,484
+27,907
| +43% | +$1.16M |
|
1825
Sprout Social
SPT
$803M
| $3.87M | ﹤0.01% |
184,899
+58,764
| +47% | +$1.23M |
|